AVTE (Aerovate) Quarterly EPS earnings growth

Aerovate Therapeutics, Inc - graphic logo of issuer AVTE

Aerovate Therapeutics (AVTE) enjoys deep trust among pulmonologists as a leading scientific visionary. The company is developing a unique inhaled imatinib that minimizes cardiac load. Current quarterly EPS dynamics confirm the market consensus, where 89.20 determines the current status of the parameter. This approach implements a targeted lung delivery strategy, significantly increasing the efficacy of therapy for severe diseases.

AVTE: aerovatetx.com Year-over-year earnings per share growth rate for the last twelve months 07/04/2022 - 04/29/2025

Aerovate Therapeutics, Inc. (AVTE) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Fundamental company valuation:Aerovate - AVTE
Finished products of aerovatetx.com

The specifics of biopharmaceuticals in the treatment of pulmonary hypertension eliminate Aerovate Therapeutics (AVTE) dependence on macroeconomic cycles, shifting the focus toward clinical trial results. The mathematical calculation of quarterly earnings per share growth measures the actual efficiency of capitalizing on these successes, allowing investors to correlate actual profitability with the asset's long-term growth rates through quarterly EPS dynamics.

Who Aerovate Therapeutics competes with

Regeneron Pharmaceuticals (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|LNTH (Lantheus Holdings) - Quarterly EPS earnings growth|Quarterly EPS earnings growth mineralystx.com|Year-over-year earnings per share growth for the last twelve months HeartFlow Inc (HTFL)|KMTS (Kestra Medical Technologies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Esperion Therapeutics ESPR|AMRN - Year-over-year net earnings per share growth for the last 12 months|Anteris Technologies Ltd - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TNYA (tenayatherapeutics.com)|CVRX: Quarterly EPS earnings growth|Milestone Pharmaceuticals, Inc. - Year-over-year earnings per one share growth for the last 12 months|CRDL (Cardiol Therapeutics Inc) - Quarterly EPS earnings growth|HeartBeam Corporation (BEAT) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tenax Therapeutics, Inc (TENX)|Year-over-year net earnings per share growth for the last 12 months Adagio Medical Holdings ADGM|Quarterly EPS earnings growth BCDA (BioCardia Inc.)|VTAK - Year-over-year net earnings per share growth for the last 12 months|ARCA Biopharma - Quarterly EPS earnings growth|ACST - Quarterly EPS earnings growth|VERV (vervetx.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share trend for the last twelve months WINT (Windtree Therapeutics Inc.)